Top Markets
Coin of the day
Theranexus Société Anonyme Theranexus Société Anonyme

Theranexus Société Anonyme

ALTHX
Rang in aandelen #15061
Theranexus société anonyme, a biopharmaceutical company, develops drug... Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain. The company was founded in 2013 and is based in Lyon, France.
Aandeelprijs
$4.66
Marktkapitalisatie
$43.92M
Verandering (1 dag)
-0.63%
Verandering (1 jaar)
338.04%
Land
FR
Handel Theranexus Société Anonyme (ALTHX)

Categorie

Dividendrendementgeschiedenis voor Theranexus Société Anonyme (ALTHX)
Het dividendrendement (TTM) van Theranexus Société Anonyme (aandelsymbool: ALTHX) per 2023-12-31 is: 0.00%
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Theranexus Société Anonyme (ALTHX) van 2015 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
2026 (TTM) 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
2015 0.00% 0.00%
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten